Advertisement

Index by Author

May 1990; 39 (5)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abid, M

    • Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes May 1990 39:534-540; doi:10.2337/diabetes.39.5.534

  2. Akanuma, Y

    • Immunological detection of phosphotyrosine-containing proteins in rat livers after insulin injection. Diabetes May 1990 39:528-533; doi:10.2337/diabetes.39.5.528

  3. Amano, K

    • Studies on autoimmunity for initiation of beta-cell destruction. V. Decrease of macrophage-dependent T lymphocytes and natural killer cytotoxicity in silica-treated BB rats. Diabetes May 1990 39:590-596; doi:10.2337/diabetes.39.5.590

  4. Asai, J

    • Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes May 1990 39:639-642; doi:10.2337/diabetes.39.5.639

B

  1. Bach, L A

    • Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes May 1990 39:557-562; doi:10.2337/diabetes.39.5.557

  2. Baker, L

    • Diabetic glycemic control and retinal blood flow. Diabetes May 1990 39:602-607; doi:10.2337/diabetes.39.5.602

  3. Benson, E A

    • Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes May 1990 39:549-556; doi:10.2337/diabetes.39.5.549

  4. Berrios, J P

    • Autoimmune destruction of islets transplanted into RT6-depleted diabetes-resistant BB/Wor rats. Diabetes May 1990 39:643-645; doi:10.2337/diabetes.39.5.643

  5. Björntorp, P

    • Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes May 1990 39:570-574; doi:10.2337/diabetes.39.5.570

  6. Braunstein, S N

    • Diabetic glycemic control and retinal blood flow. Diabetes May 1990 39:602-607; doi:10.2337/diabetes.39.5.602

  7. Brucker, A J

    • Diabetic glycemic control and retinal blood flow. Diabetes May 1990 39:602-607; doi:10.2337/diabetes.39.5.602

C

  1. Chakrabarti, S

    • Diabetic autonomic neuropathy in BB rats and effect of ARI treatment on heart-rate variability and vagus nerve structure. Diabetes May 1990 39:613-618; doi:10.2337/diabetes.39.5.613

  2. Chijiiwa, Y

    • Decreased VIP content in peripheral nerve from streptozocin-induced diabetic rats. Diabetes May 1990 39:608-612; doi:10.2337/diabetes.39.5.608

  3. Collins, P B

    • Cholesterol metabolism in alloxan-induced diabetic rabbits. Diabetes May 1990 39:626-633; doi:10.2337/diabetes.39.5.626

D

  1. D'Alessio, D A

    • Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes May 1990 39:634-638; doi:10.2337/diabetes.39.5.634

  2. Devery, R A

    • Cholesterol metabolism in alloxan-induced diabetic rabbits. Diabetes May 1990 39:626-633; doi:10.2337/diabetes.39.5.626

  3. Diem, P

    • Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes May 1990 39:534-540; doi:10.2337/diabetes.39.5.534

  4. Dunham, T

    • Fetal hyperinsulinemia and protein turnover in fetal rat tissues. Diabetes May 1990 39:541-548; doi:10.2337/diabetes.39.5.541

E

  1. Ensinck, J W

    • Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes May 1990 39:634-638; doi:10.2337/diabetes.39.5.634

F

  1. Freinkel, N

    • Uptake of myo-inositol by early-somite rat conceptus. Transport kinetics and effects of hyperglycemia. Diabetes May 1990 39:575-582; doi:10.2337/diabetes.39.5.575

  2. Fujimoto, W Y

    • Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes May 1990 39:634-638; doi:10.2337/diabetes.39.5.634

G

  1. Garcia-Palmer, F J

    • Uptake of myo-inositol by early-somite rat conceptus. Transport kinetics and effects of hyperglycemia. Diabetes May 1990 39:575-582; doi:10.2337/diabetes.39.5.575

  2. Gottlieb, P A

    • Autoimmune destruction of islets transplanted into RT6-depleted diabetes-resistant BB/Wor rats. Diabetes May 1990 39:643-645; doi:10.2337/diabetes.39.5.643

  3. Greenbaum, C J

    • Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes May 1990 39:549-556; doi:10.2337/diabetes.39.5.549

  4. Greenberg, R E

    • Fetal hyperinsulinemia and protein turnover in fetal rat tissues. Diabetes May 1990 39:541-548; doi:10.2337/diabetes.39.5.541

  5. Greene, D A

    • Diabetic autonomic neuropathy in BB rats and effect of ARI treatment on heart-rate variability and vagus nerve structure. Diabetes May 1990 39:613-618; doi:10.2337/diabetes.39.5.613

  6. Greiner, D

    • Autoimmune destruction of islets transplanted into RT6-depleted diabetes-resistant BB/Wor rats. Diabetes May 1990 39:643-645; doi:10.2337/diabetes.39.5.643

  7. Grunwald, J E

    • Diabetic glycemic control and retinal blood flow. Diabetes May 1990 39:602-607; doi:10.2337/diabetes.39.5.602

H

  1. Handler, E S

    • Autoimmune destruction of islets transplanted into RT6-depleted diabetes-resistant BB/Wor rats. Diabetes May 1990 39:643-645; doi:10.2337/diabetes.39.5.643

  2. Hirai, K

    • Application of HPLC in disposition study of A14-125I-labeled insulin in mice. Diabetes May 1990 39:563-569; doi:10.2337/diabetes.39.5.563

  3. Hisatomi, A

    • Decreased VIP content in peripheral nerve from streptozocin-induced diabetic rats. Diabetes May 1990 39:608-612; doi:10.2337/diabetes.39.5.608

I

  1. Ibayashi, H

    • Decreased VIP content in peripheral nerve from streptozocin-induced diabetic rats. Diabetes May 1990 39:608-612; doi:10.2337/diabetes.39.5.608

J

  1. Jerums, G

    • Effect of puberty on initial kidney growth and rise in kidney IGF-I in diabetic rats. Diabetes May 1990 39:557-562; doi:10.2337/diabetes.39.5.557

  2. Johnson, A H

    • Cholesterol metabolism in alloxan-induced diabetic rabbits. Diabetes May 1990 39:626-633; doi:10.2337/diabetes.39.5.626

  3. Johnson, J D

    • Fetal hyperinsulinemia and protein turnover in fetal rat tissues. Diabetes May 1990 39:541-548; doi:10.2337/diabetes.39.5.541

  4. Johnson, W T

    • Effect of streptozocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats. Diabetes May 1990 39:619-625; doi:10.2337/diabetes.39.5.619

K

  1. Kahn, S E

    • Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes May 1990 39:549-556; doi:10.2337/diabetes.39.5.549
    • Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes May 1990 39:634-638; doi:10.2337/diabetes.39.5.634

  2. Kangawa, K

    • Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes May 1990 39:639-642; doi:10.2337/diabetes.39.5.639

  3. Kang, Y S

    • Application of HPLC in disposition study of A14-125I-labeled insulin in mice. Diabetes May 1990 39:563-569; doi:10.2337/diabetes.39.5.563

  4. Kasuga, M

    • Immunological detection of phosphotyrosine-containing proteins in rat livers after insulin injection. Diabetes May 1990 39:528-533; doi:10.2337/diabetes.39.5.528

  5. Klaff, L J

    • Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes May 1990 39:549-556; doi:10.2337/diabetes.39.5.549

  6. Koshio, O

    • Immunological detection of phosphotyrosine-containing proteins in rat livers after insulin injection. Diabetes May 1990 39:528-533; doi:10.2337/diabetes.39.5.528

L

  1. Lauzon, J

    • Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes May 1990 39:583-589; doi:10.2337/diabetes.39.5.583

  2. Loftfield, R B

    • Fetal hyperinsulinemia and protein turnover in fetal rat tissues. Diabetes May 1990 39:541-548; doi:10.2337/diabetes.39.5.541

  3. Lönnroth, P

    • Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes May 1990 39:570-574; doi:10.2337/diabetes.39.5.570

M

  1. Magnuson, M A

    • Glucokinase gene structure. Functional implications of molecular genetic studies. Diabetes May 1990 39:523-527; doi:10.2337/diabetes.39.5.523

  2. Mariani, G

    • Autoimmune destruction of islets transplanted into RT6-depleted diabetes-resistant BB/Wor rats. Diabetes May 1990 39:643-645; doi:10.2337/diabetes.39.5.643

  3. Matsukura, S

    • Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes May 1990 39:639-642; doi:10.2337/diabetes.39.5.639

  4. Matsuo, H

    • Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes May 1990 39:639-642; doi:10.2337/diabetes.39.5.639

  5. Mauseth, R S

    • Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes May 1990 39:549-556; doi:10.2337/diabetes.39.5.549

  6. McCulloch, D K

    • Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes May 1990 39:549-556; doi:10.2337/diabetes.39.5.549

  7. Mitsukawa, T

    • Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes May 1990 39:639-642; doi:10.2337/diabetes.39.5.639

  8. Mordes, J P

    • Autoimmune destruction of islets transplanted into RT6-depleted diabetes-resistant BB/Wor rats. Diabetes May 1990 39:643-645; doi:10.2337/diabetes.39.5.643

N

  1. Nakazato, M

    • Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes May 1990 39:639-642; doi:10.2337/diabetes.39.5.639

  2. Nawata, H

    • Decreased VIP content in peripheral nerve from streptozocin-induced diabetic rats. Diabetes May 1990 39:608-612; doi:10.2337/diabetes.39.5.608

  3. Nepom, G T

    • Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes May 1990 39:549-556; doi:10.2337/diabetes.39.5.549

  4. Noda, K

    • Decreased VIP content in peripheral nerve from streptozocin-induced diabetic rats. Diabetes May 1990 39:608-612; doi:10.2337/diabetes.39.5.608

O

  1. O'Meara, N M

    • Cholesterol metabolism in alloxan-induced diabetic rabbits. Diabetes May 1990 39:626-633; doi:10.2337/diabetes.39.5.626

  2. Ono, H

    • Decreased VIP content in peripheral nerve from streptozocin-induced diabetic rats. Diabetes May 1990 39:608-612; doi:10.2337/diabetes.39.5.608

  3. Osei, K

    • Increased basal glucose production and utilization in nondiabetic first-degree relatives of patients with NIDDM. Diabetes May 1990 39:597-601; doi:10.2337/diabetes.39.5.597

  4. Owens, D

    • Cholesterol metabolism in alloxan-induced diabetic rabbits. Diabetes May 1990 39:626-633; doi:10.2337/diabetes.39.5.626

P

  1. Palmer, J P

    • Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes May 1990 39:549-556; doi:10.2337/diabetes.39.5.549

  2. Petrig, B L

    • Diabetic glycemic control and retinal blood flow. Diabetes May 1990 39:602-607; doi:10.2337/diabetes.39.5.602

  3. Porte, D, Jr

    • Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes May 1990 39:634-638; doi:10.2337/diabetes.39.5.634

Q

  1. Qin, H Y

    • Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes May 1990 39:583-589; doi:10.2337/diabetes.39.5.583

R

  1. Redmon, J B

    • Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes May 1990 39:534-540; doi:10.2337/diabetes.39.5.534

  2. Riva, C E

    • Diabetic glycemic control and retinal blood flow. Diabetes May 1990 39:602-607; doi:10.2337/diabetes.39.5.602

  3. Roberts, E F

    • Effect of streptozocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats. Diabetes May 1990 39:619-625; doi:10.2337/diabetes.39.5.619

  4. Robertson, R P

    • Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes May 1990 39:534-540; doi:10.2337/diabetes.39.5.534

  5. Rossini, A A

    • Autoimmune destruction of islets transplanted into RT6-depleted diabetes-resistant BB/Wor rats. Diabetes May 1990 39:643-645; doi:10.2337/diabetes.39.5.643

S

  1. Sadelain, M W

    • Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes May 1990 39:583-589; doi:10.2337/diabetes.39.5.583

  2. Sato, H

    • Application of HPLC in disposition study of A14-125I-labeled insulin in mice. Diabetes May 1990 39:563-569; doi:10.2337/diabetes.39.5.563

  3. Schoenfeld, S L

    • Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes May 1990 39:549-556; doi:10.2337/diabetes.39.5.549

  4. Schwartz, M W

    • Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes May 1990 39:634-638; doi:10.2337/diabetes.39.5.634

  5. Schwartz, S S

    • Diabetic glycemic control and retinal blood flow. Diabetes May 1990 39:602-607; doi:10.2337/diabetes.39.5.602

  6. Shaw, W N

    • Effect of streptozocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats. Diabetes May 1990 39:619-625; doi:10.2337/diabetes.39.5.619

  7. Shewey, L

    • Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study. Diabetes May 1990 39:549-556; doi:10.2337/diabetes.39.5.549

  8. Sima, A A

    • Diabetic autonomic neuropathy in BB rats and effect of ARI treatment on heart-rate variability and vagus nerve structure. Diabetes May 1990 39:613-618; doi:10.2337/diabetes.39.5.613

  9. Singh, B

    • Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes May 1990 39:583-589; doi:10.2337/diabetes.39.5.583

  10. Skipper, B J

    • Fetal hyperinsulinemia and protein turnover in fetal rat tissues. Diabetes May 1990 39:541-548; doi:10.2337/diabetes.39.5.541

  11. Slieker, L J

    • Effect of streptozocin-induced diabetes on insulin-receptor tyrosine kinase activity in obese Zucker rats. Diabetes May 1990 39:619-625; doi:10.2337/diabetes.39.5.619

  12. Smith, U

    • Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes May 1990 39:570-574; doi:10.2337/diabetes.39.5.570

  13. Sutherland, D E

    • Systemic venous drainage of pancreas allografts as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes May 1990 39:534-540; doi:10.2337/diabetes.39.5.534

  14. Svedberg, J

    • Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes May 1990 39:570-574; doi:10.2337/diabetes.39.5.570

T

  1. Taborsky, G J, Jr

    • Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells. Diabetes May 1990 39:634-638; doi:10.2337/diabetes.39.5.634

  2. Takaku, F

    • Immunological detection of phosphotyrosine-containing proteins in rat livers after insulin injection. Diabetes May 1990 39:528-533; doi:10.2337/diabetes.39.5.528

  3. Takemura, J

    • Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration. Diabetes May 1990 39:639-642; doi:10.2337/diabetes.39.5.639

  4. Tashiro-Hashimoto, Y

    • Immunological detection of phosphotyrosine-containing proteins in rat livers after insulin injection. Diabetes May 1990 39:528-533; doi:10.2337/diabetes.39.5.528

  5. Tobe, K

    • Immunological detection of phosphotyrosine-containing proteins in rat livers after insulin injection. Diabetes May 1990 39:528-533; doi:10.2337/diabetes.39.5.528

  6. Tomkin, G H

    • Cholesterol metabolism in alloxan-induced diabetic rabbits. Diabetes May 1990 39:626-633; doi:10.2337/diabetes.39.5.626

  7. Tsuji, A

    • Application of HPLC in disposition study of A14-125I-labeled insulin in mice. Diabetes May 1990 39:563-569; doi:10.2337/diabetes.39.5.563

U

  1. Umeda, F

    • Decreased VIP content in peripheral nerve from streptozocin-induced diabetic rats. Diabetes May 1990 39:608-612; doi:10.2337/diabetes.39.5.608

W

  1. Weigensberg, M J

    • Uptake of myo-inositol by early-somite rat conceptus. Transport kinetics and effects of hyperglycemia. Diabetes May 1990 39:575-582; doi:10.2337/diabetes.39.5.575

  2. Wogenrich, F J

    • Fetal hyperinsulinemia and protein turnover in fetal rat tissues. Diabetes May 1990 39:541-548; doi:10.2337/diabetes.39.5.541

Y

  1. Yoon, J W

    • Studies on autoimmunity for initiation of beta-cell destruction. V. Decrease of macrophage-dependent T lymphocytes and natural killer cytotoxicity in silica-treated BB rats. Diabetes May 1990 39:590-596; doi:10.2337/diabetes.39.5.590

Z

  1. Zhang, W X

    • Diabetic autonomic neuropathy in BB rats and effect of ARI treatment on heart-rate variability and vagus nerve structure. Diabetes May 1990 39:613-618; doi:10.2337/diabetes.39.5.613

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement